Pseudoachondroplasia

Pseudoachondroplasia (PSACH) is one of the classic "compare and contrast" dysplasias of fellowship exams, paired against achondroplasia. The name is a trap and a teaching point in one: the child has the short-limb, disproportionate habitus that superficially resembles achondroplasia ("pseudo"), but the underlying biology, the timing, the face and the spine are all different. Reflexively calling any short-limbed child "achondroplasia" is the classic error.

Why it is an orthopaedic disease. The systemic features are mild, so the patient lives a long life dominated by mechanical orthopaedic problems: malaligned, painful, early-arthritic lower limbs, and an at-risk cervical spine. The orthopaedic surgeon, not the geneticist, carries most of the lifelong care.

The gene. PSACH is caused by autosomal dominant mutations in the gene for cartilage oligomeric matrix protein (COMP) on chromosome 19 (19p13.1). COMP is a large pentameric extracellular-matrix glycoprotein of cartilage, tendon and ligament. Most mutations cluster in the calcium-binding (type-3 thrombospondin repeat) domains, with some in the C-terminal globular domain, and they compromise protein folding.

An ER storage disorder. The misfolded COMP cannot be secreted. It is retained inside the chondrocyte endoplasmic reticulum and drags its binding partners, type IX collagen and matrilin-3, in with it. The retained protein forms characteristic lamellar inclusion bodies in the rough ER and triggers ER stress, with oxidative and inflammatory injury and chondrocyte death. The net effect is failure of orderly endochondral growth, and short stature.

One gene, two diseases. PSACH and the COMP form of multiple epiphyseal dysplasia (MED) are allelic: both are COMPopathies and both are ER storage disorders. They form a spectrum on the identical gene, PSACH the more severe end (more short stature, spine involvement and ligamentous laxity) and MED the milder (mainly epiphyses, spine spared).

Inheritance. Autosomal dominant, with ~50% transmission to offspring. New (de novo) mutations and recurrence through parental gonadal mosaicism both occur, which is important for genetic counselling.

Normal at birth. Unlike achondroplasia, which is evident at birth with its characteristic facies, PSACH has no specific clinical or radiological findings at birth, and birth length is normal. The features develop slowly through childhood, so serial assessment, not a single neonatal film, makes the diagnosis.

The emerging picture. Short-limb, often rhizomelic, disproportionate dwarfism emerges in early childhood, around 2 years, as the child starts walking. It comes with a waddling (Trendelenburg) gait, marked generalised ligamentous laxity, exaggerated lumbar lordosis and lower-limb deformity.

The laxity paradox. Laxity is generalised and often striking at the hands, wrists and knees, but the elbows characteristically show restricted extension rather than hyperlaxity. A child with diffuse joint laxity, a waddling gait and limited elbow extension is a recognisable PSACH picture.

Adult height. Markedly reduced, typically around 1.0 to 1.3 m, which is on average shorter than achondroplasia (roughly 1.24-1.31 m). Quote these as conventional ranges: no PSACH natural-history cohort large enough to give proper population percentiles exists, and the figures circulate through review articles rather than from a registry.

What is spared. The face and skull are normal, with no frontal bossing and no midface hypoplasia. Intelligence is normal. There is no foramen-magnum stenosis and no characteristic respiratory compromise, unlike achondroplasia. The normal face and the absent foramen-magnum problem are the discriminators from achondroplasia an examiner is listening for; normal intelligence is shared by both and does not separate them.

Confirming it. The diagnosis is made on the evolving short stature, gait and skeletal changes, supported by radiographs and confirmed by COMP genetic testing.

The radiographic signature is an epiphyseal and metaphyseal dysplasia with spine involvement. The combination, in a child who was normal at birth, is what nails PSACH.

View larger

View larger

Where the beak sits. The location of vertebral beaking is a favourite radiology discriminator. PSACH shows anterior tongue-like (central) beaking with platyspondyly that tends to normalise in adulthood. Morquio (MPS IV) classically shows central beaking with universal platyspondyly and odontoid hypoplasia; Hurler (MPS I) and achondroplasia show antero-inferior beaking, often with a thoracolumbar gibbus.

Do not over-commit to a single beak in the viva. Describe what you see and name the differentials.

View larger

View larger

View larger

View larger

The whole point of PSACH in exams is telling it apart from its neighbours. The discriminators are gene, timing of presentation, face, spine, and which part of the bone is affected.

View larger

Against achondroplasia. Gene, face, timing and spine all separate the two. Intelligence is normal in both, so it does not help.

Against MED. The gene may be the same, since they are allelic COMPopathies, so the split lies in the phenotype. PSACH is more severe, involves the metaphyses and the spine and has marked ligamentous laxity; MED is milder, epiphyses only, with the spine essentially spared.

Not bilateral Perthes. Small, irregular, fragmented capital femoral epiphyses on both sides can be mistaken for bilateral Legg-Calvé-Perthes disease or bilateral avascular necrosis. PSACH (and MED) produce symmetrical epiphyseal change within the wider dysplastic context of metaphyses, spine, short stature and family history. Bilateral symmetrical "Perthes" should prompt a hunt for an underlying epiphyseal dysplasia.

The storage diseases. Short stature with platyspondyly and an unstable odontoid is not unique to the dysplasias. The mucopolysaccharidoses sit in the same differential, and the overlap matters because they share the atlantoaxial instability that drives the anaesthetic risk.

Morquio (MPS IVA, keratan-sulfate accumulation) has platyspondyly with odontoid hypoplasia and atlantoaxial instability like PSACH, but is given away by corneal clouding, hearing loss, valvular/aortic disease, raised urinary glycosaminoglycans and a progressive course, with normal intelligence. Hurler (MPS IH) adds coarse facies, hepatosplenomegaly, corneal clouding, intellectual disability and a thoracolumbar gibbus.

PSACH, by contrast, has a normal face and cornea, no organomegaly, normal urinary GAGs and normal intelligence, and is confirmed on COMP testing. If the face is coarse, the cornea is hazy or the urine GAGs are raised, think storage disease, not a COMPopathy.

View larger

There is no disease-modifying drug. Management is multidisciplinary, largely orthopaedic and supportive, with genetic counselling. The aims are to preserve alignment and joint function, manage early arthritis, and protect the cervical spine.

View larger

Lower-limb malalignment. Genu varum, valgum or windswept deformity is the rule, and it is often multiplanar and recurrent. In the growing child, guided growth (hemiepiphysiodesis or tension-band plating) is the workhorse; after maturity, corrective osteotomy realigns the limb.

Plan for surveillance and repeat correction through growth, and consider deformity in both planes on long-leg alignment films.

Early osteoarthritis. The dysplastic, incongruent epiphyses and the laxity drive premature osteoarthritis of the hips and knees, often from the third decade. It is often disabling, and it is the dominant long-term problem. Activity and weight management buy time, but many patients ultimately need hip or knee arthroplasty.

That arthroplasty is technically demanding, with small bones, residual deformity, ligamentous laxity and often previous osteotomies, and it benefits from preoperative planning and specialist centres.

The thoracolumbar spine. Excessive lumbar lordosis and scoliosis are the problems below the neck. Monitor them through growth and treat deformity on its merits.

Limb lengthening. Families often ask about the short stature itself. Lengthening (distraction osteogenesis) is described and can add height while correcting deformity, but it is more controversial and less predictable in PSACH than in achondroplasia. The epiphyses and joints are themselves dysplastic and ligamentously lax, so lengthening loads already-abnormal joints and may accelerate the early osteoarthritis and instability that dominate the condition, hence careful patient selection and specialist-centre care, with priority given to alignment and joint preservation over height.

Growth hormone gives little benefit here. The problem is an intrinsic cartilage-matrix / ER-storage defect, not growth-hormone deficiency, so the responsiveness seen in some other short-stature conditions does not apply.

The prognosis for life and intellect is normal; the prognosis for joints is not. AVN-mimicking epiphyseal change, joint incongruity and laxity together explain why these joints wear out early.

Beyond the arthritis, expect recurrent or multiplanar lower-limb deformity requiring staged correction through growth, cervical instability with its neurological risk, spinal deformity (scoliosis, lordosis), and reduced final height with the functional and psychosocial issues of disproportionate short stature. The orthopaedic relationship is lifelong, from guided growth in childhood to arthroplasty in adulthood.

View larger